Global Blood Therapeutics, Inc.

GBT · NASDAQ
Analyze with AI
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Assets
Cash & Equivalents$684,717$494,766$302,237$275,357
Short-Term Investments$0$66,126$307,732$202,177
Receivables$28,800$17,500$2,637$0
Inventory$58,202$40,223$1,277$0
Other Curr. Assets$30,251$13,548$14,114$8,246
Total Curr. Assets$801,970$632,163$627,997$485,780
Property Plant & Equip (Net)$82,933$88,604$79,888$14,981
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$50,057$0$85,030$114,281
Tax Assets$0$0$0$0
Other NC Assets$4,248$3,235$3,184$2,601
Total NC Assets$137,238$91,839$168,102$131,863
Other Assets$0$0$0$0
Total Assets$939,208$724,002$796,099$617,643
Liabilities
Payables$15,097$19,078$10,621$6,046
Short-Term Debt$5,670$4,836$1,866$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$67,231$55,118$58,966$27,727
Total Curr. Liab.$87,998$79,032$71,453$33,773
LT Debt$653,947$148,815$73,559$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$853$79,998$72,393$11,071
Total NC Liab.$654,800$228,813$145,952$11,071
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$742,798$307,845$217,405$44,844
Equity
Pref Stock$0$0$0$0
Common Stock$65$62$61$56
Retained Earnings-$1,289,560-$986,469-$738,916-$472,150
AOCI$100$302$754-$48
Other Equity$1,485,805$1,402,262$1,316,795$1,044,941
Total Equity$196,410$416,157$578,694$572,799
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$939,208$724,002$796,099$617,643
Net Debt-$25,100-$341,115-$226,812-$275,357